Viewing Study NCT01685333


Ignite Creation Date: 2025-12-25 @ 3:08 AM
Ignite Modification Date: 2025-12-26 @ 1:47 AM
Study NCT ID: NCT01685333
Status: COMPLETED
Last Update Posted: 2022-10-31
First Post: 2012-07-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: PK and PD Crossover Study After Single Dose, Intravenous Administration of Two Epoetin Alfa, Human Recombinant Epoetin and Eprex, in Healthy Subjects.
Sponsor: Azidus Brasil
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2013-02-28
Start Date Type: ACTUAL
Primary Completion Date: 2013-10-31
Primary Completion Date Type: ACTUAL
Completion Date: 2013-10-31
Completion Date Type: ACTUAL
First Submit Date: 2012-07-25
First Submit QC Date: None
Study First Post Date: 2012-09-14
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-10-27
Last Update Post Date: 2022-10-31
Last Update Post Date Type: ACTUAL